- Home
- Equipment
- australasia
- test sars cov 2 antigen test
Refine by
Test Sars Cov 2 Antigen Test Equipment Supplied In Australasia
6 equipment items found
Manufactured by:Ellume Limited based inEast Brisbane, AUSTRALIA
The Ellume COVID-19 Home Test is an over-the-counter, rapid self-test which detects SARS-CoV-2 antigen. The test is suitable for ages 2 years and above for over-the-counter home use in the U.S*. Clinically proven for use for people with and without symptoms, with ...
Manufactured by:Ellume Limited based inEast Brisbane, AUSTRALIA
In partnership with global diagnostics company QIAGEN®, Ellume has developed two rapid COVID-19 tests: the QIAreach™ SARS-CoV-2 Antigen Test**** for active infections and the QIAreach™ Anti-SARS-CoV-2 Total Test** ...
Manufactured by:AusDiagnostics based inMascot, AUSTRALIA
The Flowflex™ SARS-CoV-2 Antigen Rapid Test (Self-testing) allows qualitative detection of the SARS-CoV-2 nucleocapsid antigen in just 15 minutes. Designed to be easy-to-use and rigorously tested, the ...
Manufactured by:Atomo Diagnostics Limited based inLeichhardt, AUSTRALIA
A fast, accurate point of care COVID-19 antigen test for the qualitative detection of nucleocapsid protein antigens specific to the SARS-CoV-2 virus. Utilising an anterior nasal swab specimen obtained from individuals suspected of having COVID-19, the Atomo COVID-19 Antigen ...
Manufactured by:Ellume Limited based inEast Brisbane, AUSTRALIA
ellume·lab is a versatile, handheld digital device designed for healthcare professionals at the point of care. ellume·lab offers a growing range of highly accurate, rapid diagnostic tests for the detection of common infectious diseases. Two tests can be performed at the same time, with simple, animated on-screen instructions and rapid results in 15 ...
Manufactured by:Care Essentials Pty Ltd. based inNorth Geelong, AUSTRALIA
The SARS-CoV-2 / COVID-19 Antigen Test Kit is an in vitro diagnostic rapid test used for the qualitative detection of the SARS-CoV-2 Antigen (Ag) in nasopharyngeal swab specimens from individuals with symptoms within a 7 day ...